HighTower Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

HighTower Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Hold	–	-$1K	–	2448
2018 Q4	–	Hold	–	–	–	2198
2018 Q3	–	Hold	–	–	–	2274

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

HighTower Advisors's TTOO Position: Q3 2022 in Review

HighTower Advisors sold out of T2 Biosystems, Inc (TTOO) in Q3 2022, closing a stake of 12 shares — an estimated $9K sold.

HighTower Advisors first reported a position in TTOO in Q3 2018 and held it in 15 quarters. The position peaked at $214K in Q3 2018. 54 funds tracked by Wall St. Rank hold TTOO as of Q3 2022.

HighTower Advisors reported no remaining T2 Biosystems, Inc position as of Q3 2022 after selling out during the quarter.
HighTower Advisors sold 12 T2 Biosystems, Inc shares in Q3 2022, an estimated $9K.
HighTower Advisors first reported a position in T2 Biosystems, Inc in Q3 2018 and held it in 15 quarters.
HighTower Advisors's T2 Biosystems, Inc position peaked at $214K in Q3 2018.
54 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2022.

Based on HighTower Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.